Abstract | BACKGROUND: METHODS: To evaluate the effect of aerobic physical training on the expression of CNP, 90 HF patients on optimal pharmacological treatment (age 62+/-2 years, mean+/-SEM), randomly assigned in a 3 : 1 ratio to either control group (C, 19 patients) or home-based aerobic exercise-training program group (T, 71 patients), completed the protocol. Plasma assay of CNP, brain natriuretic peptide or B-type natriuretic peptide (BNP), and norepinephrine; echocardiogram; and cardiopulmonary-stress test were performed in all patients at enrollment and after 9 months. RESULTS: At baseline, in both groups, CNP plasma level was significantly related to BNP (R=0.50), ejection fraction (R=0.43), and peak oxygen uptake (VO2, R=0.43, all P<0.001). After 9 months, trained patients showed an improvement in peak VO2 (P<0.001) and ejection fraction (P<0.05), whereas norepinephrine (P<0.05), BNP (P<0.001), and CNP (P<0.001) decreased. No changes occurred in group C. In group T, the decrease in CNP was significantly related to the increase in peak VO2 (R=0.31, P<0.01), and the relation between CNP and BNP was preserved at the end of the program (R=0.41, P<0.001). CONCLUSION: Clinical and functional improvement after physical training in HF patients is associated with a decrease in adrenergic activation and in both CNP and BNP concentration. Changes in CNP plasma concentration after physical training might reflect an improvement in endothelial function.
|
Authors | Claudio Passino, Silvia Del Ry, Silvia Severino, Alessandra Gabutti, Concetta Prontera, Aldo Clerico, Daniela Giannessi, Michele Emdin |
Journal | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
(Eur J Cardiovasc Prev Rehabil)
Vol. 15
Issue 2
Pg. 168-72
(Apr 2008)
ISSN: 1741-8267 [Print] England |
PMID | 18391643
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Biomarkers
- Cardiovascular Agents
- Natriuretic Peptide, Brain
- Natriuretic Peptide, C-Type
- Norepinephrine
|
Topics |
- Biomarkers
(blood)
- Cardiovascular Agents
(therapeutic use)
- Chronic Disease
- Down-Regulation
- Echocardiography
- Exercise Test
- Exercise Therapy
- Female
- Heart Failure
(blood, physiopathology, therapy)
- Humans
- Male
- Middle Aged
- Natriuretic Peptide, Brain
(blood)
- Natriuretic Peptide, C-Type
(blood)
- Norepinephrine
(blood)
- Oxygen Consumption
- Prospective Studies
- Stroke Volume
- Time Factors
- Treatment Outcome
- Ventricular Function, Left
|